Letter to the Editor From Greenman et al: "Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study"

J Clin Endocrinol Metab. 2022 Jun 16;107(7):e3094. doi: 10.1210/clinem/dgac156.
No abstract available

Keywords: anti-androgen; cyproterone acetate; transgender.

Publication types

  • Letter
  • Comment

MeSH terms

  • Androgen Antagonists / therapeutic use
  • Cyproterone Acetate* / therapeutic use
  • Female
  • Humans
  • Transsexualism*

Substances

  • Androgen Antagonists
  • Cyproterone Acetate